skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 69  for All Library Resources

Results 1 2 3 4 next page
Refined by: Database: Springer Nature OA/Free Journals remove language: Chinese remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Material Type:
Article
Add to My Research

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-12 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0368-6 ;PMID: 31030667

Full text available

2
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
Material Type:
Article
Add to My Research

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-31 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0349-9 ;PMID: 30885279

Full text available

3
The immune landscape of esophageal cancer
Material Type:
Article
Add to My Research

The immune landscape of esophageal cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.79-79, Article 79 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0427-z ;PMID: 31771653

Full text available

4
Mucinous colorectal adenocarcinoma: clinical pathology and treatment options
Material Type:
Article
Add to My Research

Mucinous colorectal adenocarcinoma: clinical pathology and treatment options

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-13 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0361-0 ;PMID: 30922401

Full text available

5
National trend of gastric cancer mortality in China (2003–2015): a population‐based study
Material Type:
Article
Add to My Research

National trend of gastric cancer mortality in China (2003–2015): a population‐based study

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-5 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0372-x ;PMID: 31046840

Full text available

6
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Material Type:
Article
Add to My Research

Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.76-76, Article 76 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0425-1 ;PMID: 31753020

Full text available

7
Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives
Material Type:
Article
Add to My Research

Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

Cancer communications (London, England), 2019-07, Vol.39 (1), p.1-11 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0387-3 ;PMID: 31307548

Full text available

8
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Material Type:
Article
Add to My Research

Cancer cell reprogramming: a promising therapy converting malignancy to benignity

Cancer communications (London, England), 2019-08, Vol.39 (1), p.1-13 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0393-5 ;PMID: 31464654

Full text available

9
PD‐L1 and PD‐L2 expression correlated genes in non‐small‐cell lung cancer
Material Type:
Article
Add to My Research

PD‐L1 and PD‐L2 expression correlated genes in non‐small‐cell lung cancer

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-14 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0376-6 ;PMID: 31159869

Full text available

10
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy
Material Type:
Article
Add to My Research

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0383-7 ;PMID: 31221221

Full text available

11
Regulation of CD137 expression through K‐Ras signaling in pancreatic cancer cells
Material Type:
Article
Add to My Research

Regulation of CD137 expression through K‐Ras signaling in pancreatic cancer cells

Cancer communications (London, England), 2019-07, Vol.39 (1), p.1-11 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0386-4 ;PMID: 31288851

Full text available

12
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer
Material Type:
Article
Add to My Research

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer

Cancer communications (London, England), 2019-01, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-018-0346-4 ;PMID: 30606259

Full text available

13
Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
Material Type:
Article
Add to My Research

Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-9 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0356-x ;PMID: 30922396

Full text available

14
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
Material Type:
Article
Add to My Research

Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-9 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0365-9 ;PMID: 30999966

Full text available

15
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells
Material Type:
Article
Add to My Research

Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-16 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0379-3 ;PMID: 31200766

Full text available

16
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis
Material Type:
Article
Add to My Research

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis

Cancer communications (London, England), 2019-12, Vol.39 (1), p.81-81, Article 81 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0424-2 ;PMID: 31796105

Full text available

17
Expression and clinical value of programmed cell death-ligand 1 (PD-L1)in diffuse large B cell lymphoma: a retrospective study
Material Type:
Article
Add to My Research

Expression and clinical value of programmed cell death-ligand 1 (PD-L1)in diffuse large B cell lymphoma: a retrospective study

Ai zheng, 2017-12, Vol.36 (12), p.767-777, Article 94 [Peer Reviewed Journal]

2017 The Author(s) ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;The Author(s) 2017 ;ISSN: 1000-467X ;ISSN: 2523-3548 ;ISSN: 1944-446X ;EISSN: 1944-446X ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-017-0262-z ;PMID: 29246182

Full text available

18
Dual prognostic role of 2‐oxoglutarate‐dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance
Material Type:
Article
Add to My Research

Dual prognostic role of 2‐oxoglutarate‐dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-14 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0369-5 ;PMID: 31036064

Full text available

19
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
Material Type:
Article
Add to My Research

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy

Cancer communications (London, England), 2019-10, Vol.39 (1), p.1-11 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0404-6 ;PMID: 31601270

Full text available

20
Identification of genetic alterations associated with primary resistance to EGFR‐TKIs in advanced non‐small‐cell lung cancer patients with EGFR sensitive mutations
Material Type:
Article
Add to My Research

Identification of genetic alterations associated with primary resistance to EGFR‐TKIs in advanced non‐small‐cell lung cancer patients with EGFR sensitive mutations

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-15 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0354-z ;PMID: 30823937

Full text available

Results 1 - 20 of 69  for All Library Resources

Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait